US 7893206
Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof
granted A61KA61K38/40A61K48/00
Quick answer
US patent 7893206 (Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof) held by Xenon Pharmaceuticals Inc. expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Xenon Pharmaceuticals Inc.
- Grant date
- Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K38/40, A61K48/00, A61P, A61P3/00